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Abstract.  Injury to epidermis and other stratified 
epithelia triggers profound but transient changes in the 
pattern of keratin expression.  In postmitotic cells lo- 
cated at the wound edge, a  strong induction of K6, 
K16, and IG7 synthesis occurs at the expense of the 
keratins produced under the normal situation.  The 
functional significance of these alterations in keratin 
expression is not known.  Here, we report that overex- 
pression of a wild-type human K16 gene in a tissue- 
specific fashion in transgenic mice causes aberrant 
keratinization  of the hair follicle outer root sheath and 
proximal epidermis,  and it leads to hyperproliferation 
and increased thickness of the living layers (acantho- 
sis), as well as cornified layers Cnyperkeratosis). The 
pathogenesis of lesions in transgenic mouse skin be- 
gins with a reorganization of keratin filaments in post- 
mitotic keratinocytes, and it progresses in a transgene 
level-dependent fashion to include disruption of ker- 
atinocyte cytoarchitecture and structural alterations  in 
desmosomes at the cell surface. No evidence of cell 
lysis could be found at the ultrastructural  level. These 
results demonstrate that the disruption of the normal 
keratin profile caused by increased K16 expression in- 
terferes with the program of terminal differentiation in 
outer mot sheath and epidermis.  They further suggest 
that when present at sufficiently high intracellular lev- 
els, K16, along with K6 and K17, appear capable of in- 
ducing a reorganization of keratin filaments in the 
cytoplasm of skin epithelial cells. 
WRATIr~S are epithelial-specific  intermediate  filament 
(IF) 1  proteins encoded by a large multigene  family. 
The •30  proteins (mol mass 40-70 kD) can be sub- 
divided into type I or acidic  and type II or basic based on 
DNA sequence homology (Fuchs  et al.,  1981; Moll et al., 
1982a). Since keratin filament assembly begins with the for- 
marion  of a  type I-type  11  heterodimer  (Coulombe and 
Fuchs, 1990; Hatzfeld and Weber, 1990; Steinert,  1990), all 
epithelial  cells express at least one member of each keratin 
sequence subtype. Keratin  gene expression  is tightly  regu- 
lated in an epithelial  tissue-type and differentiation-specific 
manner,  although the underlying molecular basis is not well 
understood. The complex pattern of keratin gene expression 
occurring  in  stratified  epithelia  is  well conserved among 
mammalian species (Moll et al.,  1982a;  Sun et al.,  1984). 
Mitotically active basal cells express the type II keratin  K5 
and the type I keratin K14 (Nelson and Sun,  1983).  Upon 
commitment to terminal  differentiation,  basal cells down- 
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regulate the synthesis of K5 and K14 (Fuchs,  1990) and up- 
regulate that of other combinations of type I and type 1I kera- 
tins.  These combinations  appear  to  be  specific  to  the 
program of terminal differentiation being executed, and they 
vary between epithelial tissue types (Sun et al., 1984). In the 
epidermis of skin,  for instance,  the major differentiation- 
specific keratins are the type II KI and the type I K10 (Fuchs 
and Green,  1980).  Recent transgenic  mouse studies  have 
provided good evidence that the filaments built from the K5- 
K14 and K1-K10  pairs function to impart mechanical strength 
and establish cytoarchitecture in epidermal cells (Vassar et 
ai.,  1991; Coulombe et al.,  1991a; Fuchs et al.,  1992). In 
support of this, point mutations in either the K5 or K14 gene 
cause epidermolysis bullosa simplex  (EBS)  (Coulombe et 
al.,  1991b; Bonifas et al.,  1991; Lane et al.,  1992),  while 
mutations in the K1 or K10 gene cause epidermolytic hyper- 
keratosis (EHK) (Cheng et al.,  1992; Chipev et al.,  1992; 
Rothnagel  et al.,  1992).  EBS  and  EHK are distinct  skin 
blistering disorders with autosomal dominant inheritance,  in 
which  the  basal  and  suprabasal  layers  of the  epidermis, 
respectively,  rupture  in  response  to  trivial  mechanical 
trauma (See Fuchs and Coulombe,  1992).  Additional  evi- 
dence obtained in transgenic  mice (e.g.,  Baribault et al., 
1993) or other contexts (Newport et al., 1990; Janmey et al., 
1991; Torpey et al.,  1992) also point to a role for IFs in 
providing  mechanical  strength  to cells and tissues. 
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esophagus, cornea, and trachea, triggers profound changes 
in the pattern of keratin gene expression (e.g., Weiss et al., 
1984). After wounding, or in disease states associated with 
tissue hyperproliferation, these epithelial tissue adopt a simi- 
lar pattern of keratin gene expression (Moll et al., 1983; Sun 
et al., 1984). While the expression of K5 and K14 continues 
in the mitotically active cells of  the tissue, a strong induction 
of the expression of keratins K6 (type II), K16, and K17 (type 
I) occurs postmitotically (e.g.,  Stoler et al.,  1988;  Kopan 
and  Fuchs,  1989a)  at  the  expense  of the  differentiation- 
specific keratins synthesized in the normal situation. After 
physical injury to human (Tyner and Fuchs,  1986;  Mans- 
bridge and Knapp, 1987; de Mare et al.,  1990) and mouse 
epidermis (our own unpublished data), this "switch" in kera- 
tin gene expression occurs very rapidly, such that keratins 
K6 and K16 can be detected within 4-8 h at the edges of the 
wound. This makes this induction event one of the earliest 
known markers of the onset of tissue regeneration: for in- 
stance, the increase in mitotic activity that must take place 
at the wound edge does not begin before much later, i.e., at 
20-24 h after trauma (Bereiter-Hahn, 1986; de Mare et al., 
1990;  our unpublished mouse data). Functional epidermal 
regeneration is known to occur in human EBS patients (Fine 
et al., 1991) and in transgenic mice expressing dominant mu- 
tants of K14 (Coulombe et al., 1991a), suggesting that intact 
K5-K14 filaments may not be required in this process (see 
Fuchs and Coulombe, 1992). Taken together, these elements 
suggest that keratins K6, K16, and/or K17 may play a unique 
role allowing stratified epithelial tissues to achieve func- 
tional regeneration. This possibility is made all the more in- 
triguing by the recent demonstration that depletion of mater- 
nal cytokeratins from early xenopus embryos results in a loss 
of the compacted epithelial surface of the blastula, an inabil- 
ity to close a wounded surface, and a defective gastrulation 
(Torpey et al.,  1992;  see Klymkowsky et al.,  1992). 
We have initiated studies aimed at understanding the func- 
tional significance of the remarkable changes in keratin gene 
expression occurring after tissue injury and in several  dis- 
eases states.  Here, we report that the overexpression of a 
wild-type human K16 gene in a  tissue-specific fashion in 
transgenic mice results in aberrant keratinization of the hair 
follicle outer root sheath and adjacent epidermis, with hyper- 
proliferation and increases  in  the thickness of the  living 
layers  (acanthosis)  and  cornified  layers  (hyperkeratosis). 
These studies support the notion that the architecture of the 
keratin filament network is a  determinant of keratinocyte 
cytoarchitecture, and that perturbation of the latter (in the 
absence of cytolytic damage) is sufficient to significantly al- 
ter the program of terminal differentiation in stratified squa- 
mous epithelia. 
Materials and Methods 
Production and Screening of Transgenic Mice 
A previously characterized human genomic clone containing the entire K16 
gene (Rosenberg et al., 1988) was used for transgenic mouse studies. Upon 
HindIII digestion,  an ll-kb DNA fragment comprising "o6 kilobase of 5' 
upstream sequence,  the KI6 gene including all the introns,  and r~l,500 bp 
of 3' noncoding sequence  was generated and prepared for microinjection 
into fertilized  mouse embryos.  After overnight incubation in Whetten's 
medium, viable, two cell-stage microinjected eggs were reimplanted into 
the oviduct ofpseudopregnant mothers and carried to term. 3 wk after birth, 
pups were weaned,  anesthesized,  and the distal 1 cm of the tail severed. 
Genomic DNA was extracted,  restricted with BamHI, and subjected  to 
agarose gel electrophoresis and Southern analysis according to standard 
procedures.  To detect the human IO6 transgene, we used a 3.1-kb fragment 
derived from within the 5' upstream sequence of the transgene construct that 
does not hybridize to control mouse DNA. All mice used were from Jackson 
Labs (Bar Harbor, ME): C57B6/BalbC3 (agouti) mice were used for the 
production of transgenic animals and their breeding,  and in addition, 
FVB/NJ (albino) mice were also used for breeding. 
Production and Characterization of an Antiserum 
Directed against Human Keratin 16 
A  21-mer  peptide,  NH2-C-Q-T-R-P-I-L-K-E-Q-S-S-S-S-F-S-Q-G-Q-S-S- 
COOH,  corresponding to the K16 carboxy-terminal  sequence predicted 
from the human gene (Rosenberg et al.,  1988), was synthesized,  purified, 
and conjugated to maleimide-activated  keyhole limpet hemocyanin carrier 
as described by the manufacturer (Pierce Chemical Co., Rockford, IL). A 
polyclonal  antiserum was  produced  in rabbits according to established 
procedures (Hazelton Research  Products Inc., Denver,  CO).  Bleeds were 
tested by immunoblotting using purified  human recombinant keratins,  as 
well as keratin extracts prepared from human epidermal cells. Our analyses 
established that the rabbit antiserum used in this study is monospecific for 
K16 among human epidermal keratins (data not shown). 
Intermediate Filament Protein 
Extraction and Analysis by Electrophoresis 
and Immunoblotting 
Intermediate filament proteins were isolated as described (Wu et al., 1982). 
The final Triton X-insoluble pellet was solubilized  in a 50 mM Tris-HCl 
buffer containing 8 M urea and 5 % B-mercaptoethanol.  Protein concentra- 
tion was determined by the Bradford assay (Bradford,  1976) using reagents 
purchased from Bio-Rad Laboratories (Richmond, CA). Intermediate fila- 
ment proteins were resolved using SDS-PAGE (8.5 % acrylamide) and either 
stained with Coomassie blue or electroblotted onto nitrocellulose  as de- 
scribed before (Coulombe et al., 1991a). For immunoblotting, antisera used 
included the  rabbit polyclonal  anti-human KI6  produced  as  described 
above, a rabbit polyclonal anti-mouse K6 (Choi and Fuchs, 1990), a rabbit 
polyclonal  anti-K14 (Stoler et al.,  1988), AEI, a mouse monoclonal anti- 
body  (Bonhringer Mannheim  Biochemicals,  Indianapolis,  IN),  which 
recognize epidermal type I keratins (Woodcock-Mitchell  et al., 1982), and 
K8.12, a mouse monoclonal anti-K16, -103, and -K15 antibody (Sigma Im- 
munochemicals, St. Louis, MO). Bound primary antibodies were detected 
with alkaline phosphatase-coupled goat anti-rabbit or goat anti-mouse 
IgGs (Bio-Rad Laboratories). 
Morphological Studies 
For routine light microscopy  studies, tissues were fixed in Bouin's and em- 
bedded in paraffin. 5-ttm sections were either stained with hematoxylin and 
eosin,  or  were  processed  for  immunohistochemistry using  the  silver- 
enhanced immunogold  procedure as recommended by the manufacturer 
(Amersham Corp., Arlington Heights,  IL).  In addition to those already 
mentioned above, primary antisera used included a rabbit polyclonal anti- 
filaggrin (Dale et al.,  1985), a rabbit polyclonal  anti-desmoplakin I (Stap- 
penbeck and Green, 1992), and K8.60, a mouse monoclonal anti-K10 and 
Kll  (Sigma  Immunochemicals). Sections  were also prepared from fresh 
skin frozen  in dry  ice-cooled  isopentane, and labeled by indirect im- 
munofluorescence  according to standard procedures.  Bound primary anti- 
bodies were detected with an FITC-conjugated  goat anti-rabbit IgG second- 
ary  (Vector  Labs,  Inc.,  Burlingame,  CA),  or  a  biotin-conjugated  goat 
anti-mouse IgG secondary (Kirkegaard  & Perry Laboratories, Gaithers- 
burg, MD) followed by a streptavidin-Texas  red conjugate  (Vector Labs, 
Inc.).  Finally,  to identify mitotically active cells,  mice were injected in- 
traperitoneally with bromodeoxyuridine (BrdU) 2 h before death. Tissues 
were paraffin  embedded, and 5-/zm sections  were immunostained with a 
mouse monoclonat antJ-BrdU antibody (Caltag Labs, San Francisco, CA). 
For routine electron microscopy  studies,  tissues were fixed in buffered 
4% paraformaldehyde  and  I%  glutaraldehyde,  post-fixed  in 1% osmium 
tetraoxide, and embedded in LX112 epoxy-resin (Ladd Research Industries, 
Inc., Burlington, VT). For immunoelectron microscopy, tissues were fixed 
in buffered  3%  paraformaldehyde  and embedded in Lowicryl  K4M  at 
-20°C as previously described (Benday'an, 1989). Sections were immuno- 
stained with primary rabbit polyclonal  antisera directed against K16 and 
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antibody (Amersham  Corp.). The procedures  used and the specificity  con- 
trois performed  were as described  (Coulombe  et al., 1989). 
Results 
Transgenic Mice Harboring Several 
Copies of the Human 106 Gene Develop Severe 
Lesions in Skin 
To investigate the consequence of raising the intracellular 
concentration of K16 in skin and other epithelial tissues, we 
introduced the intact human K16 gene into the germline of 
mice.  The  DNA  construct  used,  a  cloned  ll-kb  human 
genomic DNA insert containing the entire K16 gene (Rosen- 
berg et al., 1988), is represented in Fig. 1 A. The coding seg- 
ment within this genomic code corresponds to that of the hu- 
man K~I6 cDNA  obtained by RT-PCR from total  mRNA 
prepared from human epidermal keratinocytes in primary 
culture  (Paladini,  R.,  and  P.  A.  Coulombe,  unpublished 
data). Transient expression of the  ll-kb genomic construct 
(subcloned into a cytomegalovirus promoter-based vector) 
in PtK2 epithelial cells resulted in the incorporation of the 
transgene product into the preexisting keratin filament net- 
work (data not shown),  confirming the original report by 
Rosenberg et al. (1988). Five founder transgenic mice having 
integrated between <1  and  "~10 copies of the human K16 
gene in their genome were produced and further analyzed. 
Two transgenic founders (mouse 4-12 and 5-7, both '~8-10 
transgene copies; see Fig. 1 B) developed skin lesions start- 
ing at 6-8 d  after birth, coinciding with the appearance of 
hair.  These lesions were initially manifested as thickening 
and scaling of the skin on an erythematous base, and they 
preferentially affected the tail, ear, neck, pelvic region, and 
other axillary areas. In founder mouse 4-12, a female, the 
lesions thereafter progressively became more severe within 
2-3 wk, with crusted erosions covering a significant portion 
of the ventral surface. Mouse 4--12 died at 2 mo of age with- 
out successful mating. In founder mouse 5-7, a male, the ini- 
tial lesions progressively healed and had disappeared after 
1 mo. The same pattern of skin lesions appearing at 6-8 d 
after birth followed  by slow healing was seen in heterozygous 
transgenic offsprings produced from founder 5-7. An excep- 
tion to this is tail skin, for which the lesions tended to be 
more severe, and left permanent mutilating scars in a subset 
(•25%)  of heterozygous  transgenic  offsprings.  A  small 
number of adult transgenic mice were characterized by a 
recurrence of the skin lesions affecting the neck and/or pel- 
vic  region.  On  the  other hand,  transgenic  founders with 
lower transgene copy number,  such as 4-14  (,'~3  copies), 
6-17 (~2 copies), and 5-13 (mosaic mouse with <1 copy), 
as well as their FI heterozygous offsprings (Fig.  1 B), have 
not featured skin lesions since birth. The 4-14 and 6-17 lines 
were bred to homozygosity (",,4-6 transgene copies; Fig.  1 
B), but failed to show the skin phenotype. As shown below, 
these nonphenotypic transgenic animals have low levels of 
transgene product in the relevant epithelial tissues. 
To establish that the skin phenotype was a direct conse- 
quence of transgene expression, we examined the effects of 
increasing further the transgene copy number in the mildly 
phenotypic 5-7 line through mating the line to homozygosity 
(--16-20 copies; Fig. 1 B). These animals rapidly developed 
skin lesions within a few days after birth (Fig.  1 C), and in 
Figure L  Production and identification of trans- 
genic mice overexpressing the human K16 gene. 
(A) Schematic of the DNA construct.  The DNA 
microinjected in mouse embryos consisted in a 
cloned  ll-kb  human  geuomic  DNA  fragment 
(Rosenberg et al.,  1988) comprising '~6 kb of 5' 
upstream  sequence, the K16 gene  including all 
eight exons (roman numerals) and seven introns 
('~3.5  kb),  and  ,~1500 bp of 3' noncoding  se- 
quence. The arrow indicates the position of the 
transcriptional start site, while AATAAA depicts 
the  position  of the  polyadenylation signal. (B) 
Southern bot analysis of  mouse tail DNAs. ~12 #g 
of genomic DNA was digested with Barn HI, and 
subjected  to  agarose  gel  electrophoresis  and 
Southern analysis according to standard  proce- 
dures. To  detect  the human K16 transgene, we used 
a 3.1-kb fragment derived from within the 5' up- 
stream  sequence  of the  ll-kb  DNA  construct. 
Lane  1,  Nontransgenic  mouse  control;  lane  2, 
founder 4-12; lane 3, F1 heterozygous offspring, 
line 5-7; lane 4, F2 homozygous  offspring, line 5-7; 
lane 5, F1 heterozygous offspring, line 4-14; lane 
6,  F2  homozygous offspring, line 4-14; lane  7, 
founder 6-17; lane 8, founder 5-13; lane 9, non- 
transgenic mouse control; lane 10, nontransgenic 
mouse  control  to  which  50  pg  transgene  was 
added. Note that founder 5-13 is a mosaic, and that a positive signal is seen upon longer exposure of the blot.  (C) Distribution of skin 
lesions on the ventral surface of phenotypic transgenic mouse. The animal on the right is an ll-d-old 5-7-F2 homozygous mouse (see lane 
4 in B), while the left one is a nontransgenic littermate. Notice the presence of darker papules of ventral skin, and of thickened skin with 
a crusty appearance on the neck and in the pelvic area. Tail skin is also severely affected. 
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gous transgenic mice were produced through matings involv- 
ing FI heterozygous animals from the 5-7 line (mild pheno- 
type)  and  the 4-14  or 6-17  line  (no phenotype).  In this 
instance, doubly heterozygous animals (,x,  ll-12 transgene 
copies) displayed skin lesions of  greater severity than hetero- 
zygous animals in the 5-7 line (data not shown). Taken col- 
lectively,  these  data  indicated  that  the  appearance  and 
severity of skin lesions in K16 transgenic mice are a function 
of transgene copy number and are independent of the site of 
transgene insertion into the mouse genome. 
The Expression of  the Human K16 Gene is Properly 
Regulated in the Skin and other Epithelial Itssues of 
Transgenic Mice 
To examine the tissue distribution of the K16 transgene prod- 
uct, we killed F1 offspring transgenic mice at various times 
after birth. Sections prepared from various tissues were im- 
munolabeled with a polyclonal antiserum raised against, and 
specific for, a 21-mer peptide corresponding to the predicted 
sequence  of  the  carboxy  terminus  of  human  K16  (see 
Materials and Methods). Control mouse skin embedded in 
paraffin did not react with this antiserum (Fig. 2 A). In con- 
trast,  nonlesional  ventral  skin  from  a  5-7-F1 transgenic 
mouse showed the expected staining pattern for K16 (Moll 
et al., 1982a;  Stark et al., 1987),  in that the epidermis was 
negative while the outer root sheath of  hair follicles was posi- 
tive (Fig.  2 B).  Specialized epidermis known to constitu- 
tively express K16, such as that of foot pads (Moll et al., 
1982a),  showed a  faint immunostaining for the transgene 
product (data not shown). In mildly lesional skin of pheno- 
type  transgenic  animals,  the  thickened  portions  of  the 
epidermis showed a strong signal, in addition to hair follicle 
profiles (Fig. 2 D). The K16 labeling in thickened epidermis 
and outer root sheath was mostly restricted to the postmi- 
totic,  suprabasal  layers,  i.e.,  as previously described  for 
Figure 2. The human K16 transgene is properly regulated in the skin of transgenic  mice. 5-/~m paraffin sections were prepared from mouse 
tissues and subjected  to immtmostaining using the immunogold-silver enhancement procedure. Sections  shown in A-D were stained  with 
a rabbit polyclonal antiserum to human K16, whereas E shows a section stained with monoelonal antibody K8.12. (A) Cross-section of 
nontransgenic  mouse epidermis.  Note the complete absence of signal in epidermis  (opposing arrowheads) and hair follicle  (hf) profiles 
(the darker band at the bottom corresponds to the natural pigmentation of a hair shaft).  (B) Cross-section of nonlesionai transgenic  mouse 
epidermis (5-7-F1 transgenic animal).  Note the absence of signal in epidermis (opposing arrowheads), while the outer root sheath epithe- 
lium of hair follicle profiles  are stained.  (C) Tangential section of tongue epithelium  in a 5-7-F1 transgenic  animal.  Note that the signal 
is restricted  to ftliform papillae (fp). (D) Mildly lesionai skin in a 5-7-F2 homozygous transgenic  animal.  Note the strong signal for the 
transgene product in the thickened portion of the epidermis immediately adjacent to the outer root sheath of the hair follicle profile. The 
signal is present in suprabasai layers, while the basal layer is negative. (E) Mildly lesional skin in transgenic founder 4-12. Note the presence 
of suprabasal  staining  in thickened epidermis.  Omission of the primary antiserum, as well as its preadsorption with the antigen,  confirmed 
the specificity  of the signal  (data not shown).  Opposing arrowheads depict the thickness  of the living layers of epidermis.  Bar,  50 #m. 
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Kopan and Fuehs,  1989a).  Identical results were obtained 
when similar sections were stained with monoclonal anti- 
body K8.12 (Fig. 2 E), which under our labeling conditions 
reacts only with K16. These data indicate that in the skin of 
adult transgenie mice with low-to-moderate transgene copy 
numbers, the human K16 gene is regulated in a tissue- and 
differentiation-specific fashion, both in its constitutive and 
inducible components. 
Examination of other epithelial tissue provided additional 
evidence that the human K16 transgene was properly regu- 
lated in transgenic mice. In dorsal tongue epithelium, only 
the  filiform  papillae  were  immunostained  (Fig.  2  C). 
Suprabasal staining was also detected in ventral tongue epi- 
thelium,  palatal  epithelium  of the  oral  mucosa,  and  in 
esophagus (Moll et al.,  1982a). In contrast, glandular epi- 
thelia of the  skin  (sweat and  sebaceous glands)  and  oral 
mucosa (salivary glands), as well as the tracheobronchial ep- 
ithelium, were negative for human K16. Simple epithelial tis- 
sues such as the liver, lung, intestine, and pancreas, as well 
Figure 3. Estimation of  the levels of  human K16 in transgenic mouse 
skin. Intermediate filament proteins were extracted from skin, elec- 
trophoresed  using  SDS-PAGE,  and  either  electroblotted  onto 
nitrocellulose or stained with Coomassie blue. Loadings are as fol- 
lows: lane 1, control (nontransgenic) mouse skin; lane 2, nontrans- 
genie mouse skin 72 h after multiple incisional wounding; lane 3, 
noulesional trunk skin from 4-14-F1 transgenic mouse; lane 4, non- 
lesional trunk skin from 5-7-F1 transgenic mouse; lane 5, lesional 
tail skin from 5-7-F1 transgenic mouse; lane 6, lesional trunk skin 
from 5-7-F2 homozygous transgenic mouse; lane 7, lesional trunk 
skin from 4-12 transgenic founder mouse; lane 8, 100 ng of FPLC- 
purified human K16. (A) Blot (1.5/zg protein/lane) incubated with 
a rabbit polyclonal anti-human  K16. (B) Blot (3 #g protein/lane) 
incubated with a rabbit polyclonal anti-mouse 1{6. (C) Blot (1.5 ~g 
protein/lane)  incubated with  monoclonal antiserum AEI,  which 
recognizes  several  type  I  epidermal  keratins.  (D)  Coomassie 
blue-stained  gel (15 #g proteins/lane). The migration position of 
molecular mass markers is indicated on the left, and the position 
of selected type I keratins is indicated on the right (see Schweizer, 
1993). Mouse  KI7, a  50-kD  protein  comigrating with  purified 
recombinant human KI4 (not shown), is depicted by dots in D. 
as all nonepithelial tissues examined, were also negative for 
the transgene product (data not shown), as expected (Moll 
et al.,  1982a). 
The Development and Severity of  Skin Lesions 
Correlate with the Levels of Transgene Product in 
Transgenic Mice 
To quantitate the amounts of KI6 transgene product present 
in lesional skin of transgenic mice, we isolated IF proteins 
from control mouse skin and from nonlesional and lesional 
transgenic mouse skin, and subjected them to electrophoretic 
and immunoblot analyses.  The results are reported in Fig. 
3; A, B and C show immunoblots reacted with anti-human 
K16, anti-mouse K6, and AE1, a monoclonal antibody react- 
ing with several epidermal type ! keratins, while D shows a 
Coomassie blue-stained gel. 
Control mouse trunk skin IF proteins, normal (Fig. 3 A, 
lane/) or wounded (Fig. 3 A, lane 2), did not react with the 
anti-human K16 antiserum under normal IF proteins loading 
conditions. A faint immunoreaction with a ~,49 kD antigen 
was detected, however, when significantly higher amounts of 
IF proteins from nontransgenic,  wounded  skin were ana- 
lyzed (data not shown). This result, together with additional 
data  referred to  below,  suggest  that  this  immunoreactive 
product is the hitherto uncharacterized mouse K16. On the 
other hand, IF extracts prepared from lesional skin of  pheno- 
typic transgenic  mice showed readily detectable levels of 
K16 transgene product (Fig. 3 A, lanes 5-7). Thus, lesional 
tail skin from a 5-7-F1 heterozygous transgenic mouse (lane 
5), lesional ventral skin from a  5-7-F2 homozygous trans- 
genie mouse (lane 6), and lesional ventral skin from founder 
4-12 mouse (lane 7) showed markedly elevated levels of the 
48-kD  transgene  product.  These  lesional  samples  also 
showed an elevated level of K6 (Fig.  3  B,  lanes  5-7)  and 
elevated levels of the type I keratin 17 (see dots in Fig. 3 D, 
lanes 5-7).  In most but not all extracts prepared from le- 
sional  skin,  a  concomitant decrease  in  the  levels  of the 
differentiationzspecific K10 occurred (Fig.  3 C, lanes 5-7). 
Differences between extracts may be partially caused by in- 
clusion of variable amounts of healthy tissues  during  the 
sampling procedure. Such changes in the keratin profile of 
skin are typical of the hyperproliferation ensuing wounding 
(Fig.  3, B-D, lane 2), or those associated with several dis- 
eases (Sun et al., 1984; Stoler et al., 1988). When equivalent 
amounts of IF proteins from nonlesional transgenic  skins 
were analyzed, however, no transgene product could be de- 
tected (Fig. 3 A, lanes 3 and 4). In fact, higher amounts of 
skin IF extracts (3×) had to be loaded to detect the 48-kD 
transgene product in these samples (data not shown). These 
data are consistent with the immunohistochemical data (Fig. 
2) showing that K16 is constitutively expressed in the outer 
root sheath (ORS) of hair follicles, but is strongly induced 
in ORS and epidermis undergoing hyperproliferation or ab- 
normal differentiation. 
Given that mouse K16 has yet to be isolated and character- 
ized (Schweizer, 1993), mouse K17 was used as a reference 
to estimate relative transgene protein levels. The expression 
of K17 is coregulated with KI6 in human skin (Moll et al., 
1982a,  1982b),  and  in  fact,  is  more abundantly  induced 
when human epidermal keratinocytes are cultured in vitro, 
a context mimicking hyperproliferation (e.g., Weiss et al., 
Takahashi  et al.  Aberrant Keratinization  in K16-overexpressing Transgenic Mice  509 Figure 4.  Light microscopy and immunohistochemistry of lesional skin in phenotypic K16-transgenic mice. (A-D and I) Hematoxylin- 
eosin-stained paraffin sections, in which the thickness of the living epidermal layers is indicated by opposing arrows. (E-H and J) Paraffin 
sections subjected to immunogold-silver enhancement staining procedure; the position of the basement membrane zone is indicated by 
arrowheads. All micrographs shown are at the same magnification. (A) Follicular  parakeratosis in trunk skin of an 11-d-old mildly pheno- 
typic transgenic mouse. Compare with B, which shows a section from corresponding area in a nontransgenic mouse. (C) Tail skin from 
a 14-d-old  control mouse. (D) Severely affected tail skin from a 14-d-old  phenotypic transgenic mouse. In addition to pronounced thickening 
of  the epidermis and inflammatory changes in the underlying dermis, note the intraepidennal blistering  caused by the disruption of cell-cell 
The Journal of Cell Biology,  Volume 127, 1994  510 1984;  Korge et al.,  1990).  The cloned mouse K17 eDNA 
(Knapp et al., 1987) encodes a 50-kD protein that can easily 
be recognized in IF extracts prepared from regenerating con- 
trol mouse skin (Fig. 3 D, lane 2) or from lesional transgenlc 
mouse skin (lanes 5-7).  Judging from the Coomassie blue 
staining,  lesional transgenic mouse  skin contains two to 
three times as much human wild-type K16 protein as mouse 
K17. On a skin tissue basis, thus, "foreign" K16 represents 
a minor fraction of total keratins (<5-7%), even in lesional 
skin. 
Follicular and Epidermal Dyskeratosis and 
Acantholysis are the Major Histopathological Changes 
in Lesional Skin of Transgenic Mice 
To determine the nature of  the skin lesions and their relation- 
ship to the expression of the transgene, we conducted light 
microscopy and immunohistochemical analyses before and 
after their inception in phenotypic mice. The initial patho- 
logical change seen in lesional transgenic skin consisted of 
a thickening of the ORS in the upper portion of hair follicles 
and of proximal epidermis, along with anomalies in terminal 
differentiation typical of hyperkeratosis and dyskeratosis 
(Fig. 4 A; a control is shown in B). The architecture of these 
two  epithelia was  perturbed,  as  evidenced by  significant 
expansions of the spinous layer (acanthosis, partly caused 
by keratinocyte hypertrophy)  and  stratum  corneum  layer 
(hyperkeratosis). Aberrancies in the granular layer, includ- 
ing its disappearance  (agranulosis),  as well as occasional 
hypergranulosis, were also noted (Fig. 4 A).  In more se- 
verely affected transgenlc skin, the follicular changes were 
more pronounced and involved larger portions of interfollic- 
ular epidermis (Fig. 4 D; see corresponding control in C). 
In particular, the frequent occurrence of large gaps between 
suprabasal keratinocytes in the perifollicular area suggested 
an impairment of cell-cell adhesion (see acantholysis in Fig. 
4 D). Moreover, the stratum corneum layer was often further 
thickened and disorganized. No signs of cytolysis could be 
detected.  Such  lesions were  seen in two independent in- 
stances, e.g., in transgenic founder 4-12,  and in heterozy- 
gous and homozygous mice derived from founder 5-7.  In 
contrast, they were not seen in control mouse skin (Fig. 4, 
B and C), or in nonphenotypic transgenic mouse skin (data 
not shown). 
Immunohistochemistry indicated that in all cases,  mild 
and severe lesional skin displayed a strong signal for the K16 
transgene product, and as expected, this signal was mostly 
found in the suprabasal  layers of ORS  and proximal epi- 
dermis (Fig. 4  E).  Immunolocalization of additional anti- 
gens further confirmed that the program of terminal differen- 
tiation was abnormal. First, a strong suprabasal staining for 
K6 was detected in lesional transgenic epidermis (data not 
shown). Second, K10, an early marker of terminal differenti- 
ation, was present only in the uppermost suprabasal layers 
(Fig. 4 F), and in some cases, was completely absent. Third, 
filaggrin, a late marker of terminal differentiation, was often 
decreased or even absent compared to nonlesional epidermis 
(Fig. 4  G). Finally, K14 localization was typical of hyper- 
proliferative epidermis (see Coulombe et al., 1991a), in that 
in addition to the basal layer, the signal extended well into 
the suprabasal compartment (Fig. 4 H). That mitotic activity 
was enhanced in lesional epidermis was confirmed using 
BrdU  incorporation  followed  by  immunohistochemistry 
with an anti-BrdU antibody (data not shown). 
In  a  subset  of 5-7-F2  homozygous transgenic  animals 
(~16-20  transgene copies),  similar skin lesions appeared 
between day 2 and 5 after birth, before hair follicle matura- 
tion had been completed. Light microscopy of such lesions 
revealed similar alterations to those described above, with 
occasional blistering within the suprabasal compartment of 
epidermis (Fig. 4 I). When immunostained with the anti- 
human K16 antiserum, these lesions showed a strong supra- 
basal staining (Fig. 4 J). In these homozygous animals, in 
fact, the epidermis was positive for the transgene product 
as soon as day 1 after birth,  i.e., before lesions appeared 
(data not shown). We noticed that several  5-7-F2 homozy- 
gous transgenic offsprings were significantly smaller than 
heterozygous and nontransgenic littermates, and they fea- 
tured epithelial thickening and dyskeratosis in portions of  the 
oral mucosa. Founder 4-12, on the other hand, died at 2 mo 
of age and had rather severe skin lesions throughout most of 
its body. Histological survey of a number of epithelial tis- 
sues, however, failed to reveal the cause of death in the most 
severely phenotypic transgenic animals. 
Cytoarchitectural Aberrations and Deficiency 
in Keratinocyte Cell-Cell Adhesion in Lesional Skin of 
Phenotypic Transgenic Mice 
To examine the skin lesions at higher resolution, conven- 
tional and immunogold electron microscopy studies were 
conducted in several phenotypic transgenic mice and in age- 
matched control mice. Skin was sampled before, as the le- 
sions developed, and after the lesions had become severe. 
Our analyses emphasized the junctional area between the 
hair follicle ORS and epidermis. The first detectable altera- 
tion was a  disorganization of keratin filament network in 
spinous  keratinocytes,  and  this  preceded  the  onset  of a 
phenotype (Fig. 5, A vs B, transgenlc and control, respec- 
tively).  Disrupted  keratin filaments were  often collapsed 
near or around the nucleus (A). In phenotypic skin, a disor- 
ganization of keratin filaments was also noted in granular 
keratinocytes (data not shown), and was accompanied by 
other alterations in cytoarchitecture. Indeed, keratinocytes 
contacts in the suprabasal layers of epidermis. (E) Anti-human K16 staining of thickened outer root sheath and proximal epidermis in 
phenotypic transgenic mouse. Note the abundance of transgene product in suprabasal layers of these epithelia. (F) Anti-K10,Kll staining 
of thickened epidermis in phenotypic transgenic mouse. The signal is only present in the uppermost layers of the epidermis. (G) 
Anti-filaggrin staining of thickened epidermis in phenotypic transgenic mouse. Note the complete absence of signal on the right side of 
the epidermis shown on this field. (H) Anti-Kl4 staining of lesional epidermis in phenotypic transgenic mouse. The signal extends from 
the basal layer to the middle of the suprabasal layers. (I and J) Acantholytic epidermis in 2-d-old phenotypic transgenic mouse. I shows 
a hematoxylin-eosin-stained section, while J shows a similar lesion immunostained with anti-human K16. Note that the acantholytic cells 
display a strong signal for the transgene product. HE hair follicle; SC, stratum corneum. Asterisks denote intraepidermal blister formation. 
Bar,' 50 t~m. 
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do, and instead, they presented a polygonal shape and the 
overall morphology of an "activated" cell, i.e., they featured 
numerous surface projections and a reduced density of des- 
mosomes, correlating with a significant  widening of intercel- 
lular space between keratinocytes (Fig.  5  C).  In severely 
dyskeratotic cells, the nucleus often had an aberrant shape 
(lobated/indented; data not shown).  These changes were 
never seen in control mouse skin (Fig. 5 B) or in nonpheno- 
typic transgenic mouse skin (data not shown). 
Examination of these lesions at higher magnification re- 
vealed additional features of significant interest. Thus, small 
protein aggregates were present in the cytoplasm of a subset 
of keratinocytes in lesional ORS  and epidermis.  The ag- 
gregates were seen initially in spinous keratinocytes, and 
their presence correlated with a  reorganization of keratin 
filaments and preceded the development of a skin phenotype 
(Fig. 6 A). In established lesions, the number of keratino- 
cytes featuring aggregates and the number of aggregates per 
cell was roughly proportional to the dyskeratotic changes at 
the tissue level. In many instances, these aggregates were in- 
termingled with randomly oriented and disorganized tono- 
filament bundles near the nucleus (Fig. 6, A vs B). A fraction 
of basal cells contained these cytoplasmic aggregates (data 
not shown), consistent with the occurrence of K16-immuno- 
positive basal cells as seen by immunohistochemistry, and 
the known existence of postmitotic keratinocytes in the basal 
layer (Schweizer et al., 1984). To ascertain the protein com- 
position of these aggregates, we performed colloidal gold 
immunoelectron microscopy.  As  expected,  all aggregates 
stained intensely with the antiserum against the K16 trans- 
gene product. K16 labeling was also detected in keratin ilia- 
merit bundles in the suprabasal layers of thickened epidermis, 
confirming that the transgene product had been recruited for 
filament assembly (Fig. 6  C).  These aggregates also con- 
tained K14, as evidenced by gold decoration using an anti- 
serum to this keratin (Fig. 6 C, inset). This suggested that 
the transgene product had successfully "displaced" a fraction 
of the K14 pool that was paired to type II keratins. Unex- 
pectedly, a limited number of small K16-positive aggregates 
were seen in the nucleus of severely dyskeratotic granular 
cells in a subset of phenotypic transgenic mice (Fig. 6 D). 
Given that (a) not all lesional transgenic skin samples showed 
these nuclear aggregates; (b) the pathogenic process was ini- 
tiated at an earlier stage of differentiation, i.e., in the lower 
spinous layer; and (c) these nuclei were otherwise normal, 
we believe it is highly unlikely that intranuclear accumulation 
of the transgene product played a significant role in eliciting 
the phenotype (for a discussion of the occurrence of wild- 
type keratins in the nucleus, see Blessing et al.,  1993). 
Remarkable changes also characterized desmosomes and 
mitochondria in lesional transgenic skin. Thus, the periph- 
eral cytoplasm of suprabasal keratinocytes in lesional trans- 
genie skin often appeared "depleted" of tonofilaments, and 
this correlated with a reduced density of desmosomes at the 
cell surface (Fig. 6, E vs B, control). In addition to this, two 
major types of anomalies were noted in the ultrastructure of 
desmosomal plaques: a conspicuous absence of tonofilament 
anchorage onto the cytoplasmic side of the plaque, and less 
frequently, the complete "halving" of the plaque at the level 
of its intercellular portion (disadhesion; Fig. 6, D-F). Such 
loss in desmosome integrity was often associated with de- 
crease in keratinocyte cell-cell adhesion (acantholysis; see 
Fig. 4 I), and was more prominent in the spinous layer com- 
pared to the granular layer.  Alterations in the distribution 
and ultrastructure of mitochondria also occurred in lesional 
transgenic ORS and epidermis. In mildly phenotypic skin, 
one or two electron-dense spherical inclusions were present 
in some mitochondria of suprabasal cells (Fig. 6 F). The in- 
tracellular distribution and ultrastructure of mitochondria 
appeared otherwise normal. In severely dyskeratotic skin le- 
sions, however, mitochondria were often clustered and en- 
larged, and contained up to four of these inclusions in their 
matrix (Fig. 6 F, inset), albeit the keratinocytes featuring 
them were clearly not degenerating. Such alterations in des- 
mosomes  and  mitochondria  were  never  seen  in  control 
mouse skin (e.g., Figs. 5 C and 6 B) or in nonphenotypic 
transgenic mouse skin. 
Probing the Relationship between Keratin 
Expression and Desmosomal Alterations in Lesional 
Transgenic Mouse Skin 
Taken together, our immunohistochemical and ultrastruc- 
tural analyses in lesional transgenic outer root sheath and 
epidermis implied the existence of a complex relationship 
between (a) aberrant keratinization; (b) the intracellular lev- 
els of the type I keratins K16 and K10, and (c) desmosomal 
alterations. To probe the nature of this relationship further, 
we performed double-immunofluorescence labeling experi- 
ments using anti-K16, anti-K10/Kll, and anti-desmoplakin I 
antisera on fresh frozen sections prepared from ventral skin 
lesions of moderate severity. Desmoplakin I is a major struc- 
tural component of desmosomes (Jones and Green,  1991). 
Representative results  are  shown on Fig.  7;  A  shows  the 
results of double labeling for K16 and K10/K11. In epidermis 
showing a near-normal thickness and architecture, the onset 
of K10/K11 expression clearly precedes and appears to ex- 
ceed that of K16. Conversely, in thickened epidermis, ex- 
pression of K16 precedes that of K10/KI  1, and all three kera- 
tins are present in the upper suprabasal layers (Fig. 7 A). 
These results are in good agreement with the single-labeling 
experiments reported in Fig. 4 and the protein data reported 
in Fig. 3. Fig. 7, B-E, show the results of double-labeling for 
K10 and desmoplakin I. In epidermis showing a normal ar- 
chitecture and normal distribution of K10, the desmoplakin 
signal is also normal, in that it is located at the cell-cell inter- 
face throughout the epidermis (Fig. 7, B and C) and the outer 
root sheath of hair follicles (not shown). In striking contrast, 
thickened and disorganized epidermis is characterized by an 
almost complete absence of K10 signal, and it also shows 
aberrancies in the distribution of desmoplakin I (Fig. 7, D 
and E). Indeed, this latter appears discontinuous and/or ir- 
regular in some areas (Fig. 7, D and E). These data strongly 
suggest that in lesional transgenic mouse epidermis, des- 
mosomal alterations were not solely a function of abundant 
K16 expression, but also of  a reduced expression of K10 and, 
possibly, of other differentiation-specific keratins. 
Discussion 
Modest Overexpression of Intact Human KI6 Results 
in Skin Lesions in Transgenic Mice 
In this study, we have introduced the intact human K16 gene 
Takahashi et al. Aberrant  Keratinization in K16-overexpressing  Transgenic Mice  513 Figure 6. Electron microscopy of cellular alterations in epidermis of phenotypic K16-transgenic mice. (A, B, D, E, and F) Conventional 
transmission electron microscopy. (C) Immunogold electron microscopy. (A) Presence of protein aggregates (a) intermingled with keratin 
filaments (f) in the cytoplasm of a spinous layer keratinocyte in mildly dyskeratotic transgenic mouse epidermis. This contrasts with the 
ultrastructure of spinous cells in control mouse epidermis shown in B. No such aggregates are seen, and the keratin filaments (f) are orga- 
nized radially in the cytoplasm, and are anchored at the level of desmosomes at the cell surface (arrowheads). (C) Immunogold staining 
of acantholytic transgenic epidermis with an anti-human K16 antiserum. The keratin filament bundles are decorated by gold particles (ar- 
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the skin, particularly, and in several other epithelial tissues 
surveyed, it is regulated in a tissue-specific (human K16-1ike) 
fashion. Transgenic mouse lines with low transgene copy 
numbers and low levels of expression did not show any de- 
tectable alteration in the relevant skin epithelial tissues. In 
striking  contrast,  however,  transgenic  mice  with  higher 
transgene copy numbers and more substantial transgene ex- 
pression were characterized by skin lesions consisting in 
papules,  crusty erosions,  and  scaling.  Skin lesions  were 
more prominent in preferential body sites.  Obvious sites of 
predilection included intertriginous areas (regions showing 
skin  folds),  tail  skin,  and  in  the  more  severely affected 
animals, the ventral body surface. The reasons underlying 
the relative specificity of the lesional process are currently 
unknown. 
Morphologically, we have shown that in such transgenic 
animals, the lesional process began in the upper portion of 
hair follicle ORS, where the transgene is known to be con- 
stitutively expressed (Moll et ai., 1982a; Stark et ai., 1987). 
Given that the epidermis is continuous with the ORS, and 
that various types of conditions, including hyperprolifera- 
tion, are associated with the induction of K16 expression in 
the  epidermis  proper  (Weiss  et al.,  1984;  Stoler  et  al., 
1988), transgene expression did occur in the epidermis prox- 
imal to morphologically abnormal ORS. The distribution of 
several markers of the program of terminal differentiation in 
affected epidermis was abnormal in phenotypic transgenic 
mice, correlating with profound changes in the architecture 
of the tissue,  as well as the occurrence of a  pronounced 
hyperkeratosis (thickening of stratum corneum layer). Our 
analyses provided strong evidence that after its initiation in 
ORS, the pathogenic process progressed according to the ex- 
tent of K16 expression, i.e., its severity was determined by 
transgene copy number and transcriptional activity in each 
of these copies. This interpretation is supported by the mor- 
phological and biochemical data accumulated in our various 
transgenic mouse lineages. 
In at least one subset of transgenic mice (homozygous 
offsprings derived from 5-7 founder), skin lesions appeared 
within days after birth, well before hair follicle morphogene- 
sis had been completed (see Kopan and Fuchs, 1989b).  Im- 
munohistochemicai studies  revealed  the  presence  of the 
transgene product in epidermis in 1-d-old pups, i.e., before 
the skin lesions develop between 2 and 4 d after birth. While 
the K6, K16, and K17 genes are expressed transiently in hu- 
man epidermis during fetal development, the adult keratin 
pattern is already established in newborn epidermis and thus 
excludes these keratins (Moll et al., 1982b).  The human KI6 
gene has been reported to be regulated at the transcriptional 
and posttranscriptional levels in the epidermis (Tyner and 
Fuchs, 1986).  Therefore, it is conceivable that a nuclear or 
a cytoplasmic factor involved in the repression of the K16 
gene or mRNA, respectively, was being titrated out in these 
high transgene copy number mice, thus leading to unap- 
propriate (ectopic) expression. Further characterization of 
these mice should allow us to distinguish among these and 
other possibilities. 
An  important  question  left unresolved  is  whether  the 
phenotype in transgenic mice resulted from an increased ex- 
pression of a truly wild-type K16sequence, or alternatively, 
whether the human K16 sequence is perceived as a "mutant" 
by mouse epithelial cells. There is confusion in the literature 
regarding mouse K16 which, as it turns out, has yet to be 
characterized (see Schweizer,  1993). Examination of  epider- 
mal keratin orthologues in mice and humans reveals very 
high sequence identity scores, increasing the likelihood that 
these sequences are functionally  interchangeable. Consistent 
with this, epithelial lesions were not described in previous 
studies in which human K14 (Vassar  et al.,  1989),  human 
K18 (Abe and Oshima, 1990),  human K1 (Rosenthal et al., 
1991), and bovine K19 (Bader and Franke, 1990) were "over- 
expressed" in a tissue-specific fashion in transgenic mice. 
One exception to this is the brittle hair phenotype generated 
by massive overexpression (,0250 copies) of a sheep hair- 
specific  type  II  keratin  gene  in  the  mouse  (Powell  and 
Rogers, 1990).  Before we can formally attribute the pheno- 
type observed in transgenic mice to the increased expression 
of K16, a control experiment in which the expression of K14 
or K10 is driven to comparable levels in transgenic mouse 
skin is needed. 
On the other hand, the tissue-specific expression of a dom- 
inant negative mutant engineered in the human type I K10 
sequence resulted in the trauma-induced lysis of keratino- 
cytes in the  spinous layer of transgenic mouse epidermis 
(Fuchs et al., 1992). The mouse phenotype produced closely 
resembled EHK, a genetic skin disease caused by point mu- 
tations in either one of the K1, K9, or K10 genes (reviewed 
by Coulombe and Fuchs,  1994).  As expected, cytolysis of 
postmitotic epidermal cells stimulates mitotic activity in the 
basal layer, and probably accounts for the chronic hyper- 
proliferation,  significant thickening of the epidermis, and 
hyperkeratosis typical of this disorder (Fuchs et al., 1992). 
The comparison of these results with those obtained in our 
studies is relevant because after its expression is induced in 
epidermis, the K16 transgene is regulated like a K10 gene. 
Quite remarkably, a surprising degree of hyperproliferation, 
acanthosis (epidermal thickening), and hyperkeratosis, oc- 
curred in the absence of detectable cytolysis in our phe- 
notypic transgenic mice. Fuchs et al. (1992)  suggested the 
rowheads), as are nonfilamentous  protein aggregates (arrows). These aggregates are also decorated with gold particles when an anti-K14 
antiserum is used (inset). Note also the presence of  large gaps between keratinocytes (asterisks). (D) Illustration of  the occasional presence 
of small protein aggregates  in the nucleoplasm  of  a subset of  transgenic keratinocytes  (arrowheads). Immunoelectron  microscopy  confirmed 
that these nonfilamentous  aggregates  contain the transgene product (not shown). The ultrastructure of the nucleus appears normal. Again, 
note the relative paucity of  desmosomes at the cell surface and the wide gaps between cells. (E) Desmosomal alterations in spinous keratino- 
cytes of phenotypic transgenlc mouse epidermis. The desmosomes, or their remnants, are depicted by arrowheads. In many instances, 
no keratin filaments are attached onto the cytoplasmic side of the plaque, and several plaques are separated at the level of the intercellular 
domain, causing gaps between keratinocytes (asterisks). Compare these altered desmosomes with those depicted in B. (F) Mitoehondrial 
alterations in the suprabasal keratinocytes of phenotypic transgenic mouse skin. One or several spherical and electron-dense inclusions 
are present in the mitoehondrial matrix, and several of these mitochondria are clustered. The inset shows mitochondria that are enlarged 
and present an unusually electron-lucent matrix. N, nucleus. Bars, 2 #m. (Bar in A also applies to B, D, and E). 
Takahashi et al. Aberrant Keratinization in K16-overexpressing Transgenic Mice  515 Figure 7. Double-immunofluoreseence labelings in moderately lesional transgenlc mouse ventral skin. 5-7-/~m sections were prepared from 
freshly frozen ventral skin sampled from a transgenlc mouse with a phenotype of moderate severity, and were processed for double- 
immunofluorescence labeling as described in Materials and Methods. (A) Superposed immunofluorescence signals for K16 (FITC channel, 
green) and K10/Kll (Texas red channel, red). The thickness of the epidermis is depicted by opposing arrowheads. Note that in the thinner 
epidermis at left, the K10/Kll signal clearly predominates over the KI6 signal. In contrast, in the thickened epidermis on the right, the 
first layer of suprabasal cells expresses only K16 because it is only FITC positive. The remainder of the suprabasal layers are yellow-orange: 
this color is the result of superposition of the signals for K16 (green) and KI0/Kll (red), and it indicates that both keratins are present. 
(B-E) Double immunofluorescence for desmoplakin I (FITC channel, green) and KI0/Kll (Texas red channel, red). (B) The signal for 
The Journal of Cell Biology,  Volume 127, 1994  516 existence of pathways of communication between the pro- 
liferating and differentiating compartment in epidermis; our 
findings further extend this, and they indicate that these path- 
ways could be exquisitely sensitive to alterations in the nor- 
mal program of terminal differentiation. 
Increased 106 Expression in Transgenic Mouse Skin 
Results in Remarkable Cellular Alterations 
Our results clearly established that at the cellular level, the 
overexpression of a wild-type human K16 gene in transgenic 
mouse skin, along with the other alterations in the program 
of keratin gene expression, is associated with a major reor- 
ganization of keratin filaments in posmaitotic keratinocytes 
of the ORS and epidermis.  Ultrastructural examination of 
mild and severe skin lesions at early stages of their develop- 
ment indicated that this reorganization initially consisted of 
a redistribution of filament bundles near or around the nu- 
cleus, thus partially depleting the peripheral cytoplasm of 
keratinocytes of keratin filaments. Such changes in keratin 
filament organization preceded (and thus might have been 
responsible for) the onset of several other types of cellular 
alterations in transgenic keratinocytes. These alterations in- 
eluded changes in keratinocyte cell shape and cytoarchitec- 
ture,  in the number and structure of cell surface desmo- 
somes, and of organdies such as mitochondria. 
The notion that keratinocyte cytoarchitecture is partly de- 
pendent on the organization of the keratin filament network 
is already established. Indeed, aberrations in nuclear shape 
and in the spatial distribution of cytoplasmic organdies have 
been described in EBS and EHK diseases, two keratin gene 
disorders in which the keratin filament network of basal and 
suprabasal epidermal cells, respectively, is structurally and 
functionally defective (Fuchs and Coulombe,  1992).  Our 
results extend these previous findings, and they suggest that 
the "disruption" of the organization of keratin filaments in 
postmitotic epidermal keratinocytes caused by plain altera- 
tions in the program of keratin gene expression interferes 
with the normal flattening and reorganization of the cell's 
main axis known to occur under normal differentiating con- 
ditions. In future studies, we will investigate the specific con- 
tribution of greatly elevated intracellular levels of  K16 (along 
with K6 and K17) in the causation of such major cytoar- 
chitectural changes in skin keratinocytes, for this would have 
major implications for wound healing in complex epithelia. 
Whether keratin filaments play a direct role in maintaining 
the structure and function of desmosomes at the cell surface 
is, on the other hand, still a matter of debate. Transfection 
of mutant keratin cDNAs in cultured F9 embryonal carci- 
noma ceils (Trevor, 1990) and in SCC13 epidermal cells (Al- 
bers and Fuchs, 1989) results in quantitative and/or qualita- 
tive anomalies in the distribution of desmosomal antigens. 
Likewise, expression of  desmoplakin mutants in cultured ep- 
ithelial cells interferes with assembly of desmosomes at the 
cell surface and causes aberrations in the organization of  ker- 
atin filaments (Stappenbeck and Green, 1992).  Moreover, 
there are studies reporting a lower number of desmosomes 
in  lesional  epidermis  of EBS  patients  (Ito  et  al.,  1991; 
McGrath et al., 1992),  and in patients suffering from some 
forms of EI-IK (e.g., Moriwaki et al., 1988).  However, evi- 
dence against a major role of keratin IFs in desmosome as- 
sembly and function stemmed particularly from the study of 
homozygous K8 null mouse ES cells. Indeed, when stimu- 
lated to undergo embryonic body formation in vitro, these 
cells are capable of forming a simple polarized epithelium 
with normal desmosomes in spite of the complete absence 
of keratin filaments (Baribault et al., 1993). Thus, there may 
exist multiple pathways for the assembly of functional des- 
mosomes at the cell surface, and their relative importance 
may vary among epithelial cell types. Our results suggest 
that at least some types of  kera.tin filaments could play a func- 
tional role in the maintenance of functional desmosomes at 
the cell surface in ORS and epidermis. One can envision sev- 
eral mechanisms through which the composition and struc- 
ture of  keratin filaments could directly or indirectly influence 
cell-cell adhesion between keratinocytes. One possibility is 
that filaments enriched in particular keratins could interact 
with key structural components of desmosomes and influence 
their normal assembly or function. Alternatively, regulatory 
components that are directly involved in desmosome assem- 
bly and dynamics could be physically associated with such 
keratin filaments, and thereby depend on IF organization in 
the cytoplasm. Yet another alternative is that the disruption 
of the normal organization of keratin filaments could, under 
some conditions, trigger the production/activation of factors 
involved in desmosome regulation. Finally, the protein com- 
position of desmosomes undergoes modifications as epider- 
mal cells differentiate (Arnemann et al.,  1993),  and this 
"maturation process" may depend on the cytoplasmic organi- 
zation of keratin filaments. Additional studies will be re- 
quired to settle among these and other possibilities,  and 
again, to determine the specific contribution of  the increased 
levels of K16, K6, and K17 to the observed effects on desmo- 
somes in our transgenic mice. 
Finally, intriguing changes were noticed in the ultrastruc- 
ture of mitochondria in moderately and severely lesional 
transgenic skin. Smooth-surfaced, spherical, and electron- 
dense inclusions of various sizes were present in the mito- 
chondrial matrix. These inclusions do not contain keratin, 
as indicated by our immunoelectron microscopy studies. In- 
terestingly, similar mitochondrial inclusions have been de- 
scribed in mouse skin subjected to UVB irradiation or tumor 
promoters, such as TPA or mezerein (see Feldman et al., 
1990, and references therein). At the present time, however, 
we do not know the significance or the metabolic conse- 
quences of the occurrence of such mitochondrial alterations 
in transgenic keratinocytes, which clearly did not show any 
signs of degeneration. 
desmoplakin I in a near-normal area of transgenic epidermis. The signal is concentrated at the cell--eel boundaries. (C) The exact same 
field, except that the signals for desmoplakin  ] and KI0/Kll are now superposed. Keratins K10/KI1 are present throughout the suprabasal 
layers, and the boundaries between suprabasal keratinoeytes  is intensely yellow.  (D) The desmoplakin  I signal in a lesional area of  transgenic 
mouse epidermis. Note that in several areas the signal is irregular and discontinuous (arrowheads) compared to B. As shown by the super- 
posed signals in E, this region of epidermis contains virtually no KI0/Kll. In E, the arrow depicts the pronounced hyperkeratosis. Bar, 
50 #m. 
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K16-overexpressing Mice 
A priori, the finding that a relatively modest overexpression 
of a wild-type keratin gene in a tissue-specific fashion led to 
the  formation of multiple small  aggregates in  transgenic 
mouse skin keratinocytes is a surprising one. Identifying the 
mechanism(s)  responsible  for this accumulation will sig- 
nificantly enhance our understanding of the biology of kera- 
tin filaments. Three main possibilities ought to be consid- 
ered. First, as mentioned above, it could be that human K16 
behaved as a (mild) keratin mutant able to perturb mouse en- 
dogenous keratin filaments at suitably high intracellular lev- 
els. The cloning and characterization of the mouse keratin 
gene orthologue to human K16 should be informative at that 
level. Second, it may be that the extent of type I keratin over- 
expression in transgenic mouse keratinocytes was such that 
it exceeded the capacity of the posttranscriptional degrada- 
tion mechanisms thought to maintain a proper balance be- 
tween type I and type ]I keratins in the cytoplasm (Kulesh 
et al., 1989; Lersch et al., 1989), leading to their accumula- 
tion as small aggregates. If true,  this implies that similar 
results could have been obtained if the expression of other 
type I keratins had been placed under the same regulatory 
sequences. Third, it may be that K16 intrinsically displays 
unconventional assembly properties, and that its expression 
to relatively high intracellular levels serves the purpose of 
promoting a reorganization of the keratin filament network. 
Preliminary  findings  stemming  from  in  vitro  assembly 
studies  with  purified  human  epidermal  keratins  provide 
some insights in that respect. Indeed, we have found that type 
I-type II heterotypic complexes containing K16  are  sig- 
nificantly less stable in urea buffer than those containing K14 
as their type I keratin, and moreover, that the efficiency with 
which K16 assembles into 10-nm filaments with either K5 
or K6 as type II partner in vitro is also significantly lower 
(Paladini, R., and P.  A.  Coulombe, unpublished observa- 
tions). The completion of  these and additional studies should 
allow us to better understand the mechanisms responsible 
for the formation of these small aggregates in the skin ker- 
atinocytes of our K16-overexpressing  mice. 
Given that the type I keratin genes encoding K14, K10, and 
K9 have been implicated in human genetic skin diseases 
(Coulombe and Fuchs, 1994),  it is possible and even likely 
that mutations in the K16 gene underlie a human disease as 
well. We do not know the extent to which the phenotype that 
could arise from the tissue-specific expression of a dominant 
negative K16 mutant in transgenic would resemble the one 
described in the present study, which involved overexpres- 
sion of the wild-type human K16 gene. Yet, the morphologi- 
cal attributes of lesional skin in our phenotypic transgenic 
mice showed an intriguing resemblance to those associated 
with some skin diseases featuring acantholytic dyskeratosis 
(Waldo  and Ackerman,  1978).  Among such diseases one 
finds Darier and Hailey-Hailey diseases, two related genetic 
skin disorders having an autosomal dominant inheritance 
(Burge, 1992; Burge and Wilkinson, 1992). Histological ex- 
amination of  the lesions in Haliley-Hailey and especially Dar- 
ier patients reveals abnormal keratinization and acantholysis 
in the suprabasal layers. Remarkably, desmosomes are re- 
duced at the keratinocyte cell surface, while those present 
are frequently abnormal, with tonofilament detachment and 
disruption of the plaque at their intercellular domain. It is 
generally believed that a  functional defect in desmosomal 
component(s) is responsible for both these diseases (Burge, 
1992; Burge and Wilkinson, 1992). The Darier disease locus 
has recently been mapped in several pedigrees to 12q23-24 
(Craddock et al.,  1993;  Bashir et al.,  1993;  Parfitt et al., 
1994),  i.e., outside of chromosomal loci known to contain 
gene clusters encoding known structural components of des- 
mosomes, and several centimorgans away from a large clus- 
ter of type II keratin genes located at 12q11-13 (Rosenberg 
et al., 1991). The Hailey-Hailey locus has yet to be mapped, 
but linkage to the two major clusters of keratin genes (type 
I and type II) and to the Darier locus have been ruled out 
(Welsh et al.,  1994).  While it appears quite unlikely that 
Darier  and Hailey-Hailey are keratin gene disorders,  our 
data suggest that these diseases may not necessarily involve 
a structural defect in an integral desmosome component be- 
cause some of the typifying ultrastructural alterations as- 
sociated with these diseases were produced by overexpres- 
sion of a keratin gene in transgenic mouse skin. 
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